Retrobulbar Needle - Atkinson
Navigation Links
Retrobulbar Needle - Atkinson
| Products | Retrobulbar Needle - Atkinson |
| Company | Hurricane Medical |
| Item | Retrobulbar Needle - Atkinson |
| Features | |
| Description | For injecting anesthetics into the muscle cone. 23G x 1 1/2 in (.60 x 38mm) |
| Info | Hurricane Medical Customer Service: (877) 446-1444 Web site: http://www.hurricanemedical.com |
Related medicine products :
1. Retrobulbar Needle, 23 g. Atkinson style bevel.
2. Retrobulbar Needle, 25 g. Atkinson style bevel.
3. Retrobulbar Needle - Sharp
4. Needle and Gouge Spud Set
5. Replacement Needle Tip
6. Needle Knife, Straight, Full Handle, Non-Reflective, 0.74 mm Width
7. Peribulbar Needle, 23 g. Atkinson style bevel.
8. Peribulbar Needle, 25 g. Atkinson style bevel.
9. Anterior Chamber Needle, 20 g. Angled
10. Anterior Chamber Needle, 23 g. Angled
11. Anterior Chamber Needle, 25 g. Angled
Breaking Medicine News(10 mins):Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 2Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 3Health News:Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss 4Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 2Health News:Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative 3Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 2Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 3Health News:White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices 4Health News:Life Science And Medical Device Software Engineering Consulting Firm Full Spectrum Software Announces 12 New Contract Wins In 2009 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 2Health News:Obesity and Inactivity -- The Biggest Threat to the Nation's Health 3
[0] Study Finds Family Members Play Critical Role in Addressing Loved Ones' Hearing Loss[0] Union Hospital, Hong Kong, Selects First DataBank's Electronic Drug Information in Medication Safety Initiative[0] White Pine Systems and Pediatric Web Announce Partnership to Deliver Interoperable and Brandable PHR Solution for Pediatric and Family Practices [0] Life Science And Medical Device Software Engineering Consulting Firm Full Spectrum Software Announces 12 New Contract Wins In 2009[1] Obesity and Inactivity -- The Biggest Threat to the Nation's Health
Breaking Medicine Technology:Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 2Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 3Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7Royalty Pharma Announces that Alexander von Perfall Joins Management Team 2LFAGW to Run Could I Have Lupus 3F Workshop on July 26 3B Mystics Game Follows 51830 1LFAGW to Run Could I Have Lupus 3F Workshop on July 26 3B Mystics Game Follows 51830 2LFAGW to Run Could I Have Lupus 3F Workshop on July 26 3B Mystics Game Follows 51830 3ResMed Announces Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year End 2009 Results 51826 1ResMed Announces Conference Call and Webcast to Discuss Fourth Quarter and Fiscal Year End 2009 Results 51826 2New Data Say Uninsured Account for Nearly One Fifth of Emergency Room Visits 51823 1New Data Say Uninsured Account for Nearly One Fifth of Emergency Room Visits 51823 2New Data Say Uninsured Account for Nearly One Fifth of Emergency Room Visits 51823 3
[0] Inability of Pixantrone to Form Toxic Iron Complexes Results in Significant Reduction in Cardiac Cell Toxicity Compared to Currently Marketed Anthracyclines[0] ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease[0] Royalty Pharma Announces that Alexander von Perfall Joins Management Team
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |